First month from $139 on compounded plansFirst month from $139on compounded plans
Pallas
All states

GLP-1 weight loss in Idaho

Visit type
No video visit required
Licensing
Idaho State Board of Medicine
Updated
Licensed by
Idaho State Board of Medicine
Telehealth
No video visit required
Semaglutide injections
Available
Tirzepatide injections
Available
Medicaid
Limited coverage
Shipping
2–3 business days

Idaho residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — whether you are in the Boise metro, eastern Idaho, or a rural county without a nearby obesity medicine specialist. Pallas Health pairs you with a board-certified provider licensed in Idaho who reviews your intake — by secure message in most cases — and, if appropriate, sends your prescription to a US-licensed pharmacy that ships to any Idaho address in 2–3 business days.

How telehealth prescribing works in Idaho

Idaho permits licensed providers to establish a patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review, when the standard of care is met.

Idaho requires any provider writing a prescription to an Idaho resident to hold an active Idaho medical license — an out-of-state license is not enough. Under the Idaho Virtual Care Access Act (Idaho Code §54-5701 and following), a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review of a completed intake, provided the standard of care is met and documentation is appropriate. Every Pallas provider who treats Idaho patients is individually licensed by the Idaho State Board of Medicine. GLP-1s are not controlled substances, so Idaho's additional controlled-substance telemedicine rules do not add friction here, but our providers still take a complete history, screen for contraindications like a personal or family history of medullary thyroid carcinoma, and arrange follow-up to monitor response and titrate the dose.

Medicaid & insurance in Idaho

Idaho Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited, and compounded GLP-1s are not covered. Pallas is a cash-pay service, so Medicaid coverage does not apply to our prescriptions. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.

Simple cash-pay pricing in Idaho

No insurance, and the same price in every Idaho ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.

Compounded

  • Semaglutide injectionsFrom $139
  • Tirzepatide injectionsFrom $179

Brand-name

  • Wegovy® injectionsFrom $499
  • Zepbound® injectionsFrom $499
  • Ozempic® injectionsFrom $499
  • Mounjaro® injections$1,099/mo
  • Wegovy® pillFrom $299
  • Foundayo™ pillFrom $299

See the full Idaho cost guide

Semaglutide vs tirzepatide in Idaho

Both are once-weekly injections available to Idaho patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.

In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.

Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Idaho — our full semaglutide vs tirzepatide comparison covers the deeper differences.

Cities served in Idaho

Partner pharmacies ship to every ZIP code in Idaho, including:

  • Boise
  • Meridian
  • Nampa
  • Idaho Falls
  • Caldwell
  • Pocatello
  • Coeur d'Alene
  • Twin Falls
  • Post Falls
  • Lewiston
  • Rexburg
  • Moscow
  • Eagle
  • Kuna
  • Ammon
  • Chubbuck

Idaho GLP-1 questions

Start the online intake (about 5 minutes). An Idaho-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.

Same intake as semaglutide. If appropriate, an Idaho-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.

Yes. An Idaho-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.

Yes. Idaho nurse practitioners prescribe independently, with no physician agreement required. GLP-1s are not controlled substances, so they can be prescribed by telehealth.

Several do. Check that its clinicians are licensed in Idaho, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves Idaho.

No. Idaho allows a licensed clinician to review your intake by secure message and prescribe without a scheduled video call. They may ask for a video visit only if your history calls for it.

Intake takes about 5 minutes, and an Idaho-licensed clinician usually reviews it within 1 to 2 business days. If prescribed, the pharmacy ships in 2–3 business days.

Yes. Partner pharmacies ship to every Idaho ZIP code, from Boise and Meridian to the smallest towns, usually in 2–3 business days. Remote addresses may take an extra day.

Several do. Check that its clinicians hold an Idaho license, that it uses US-licensed pharmacies, and that it is LegitScript-certified (the database is public). Pallas serves Idaho.

Most Idaho patients receive their medication within 2–3 business days of the pharmacy filling the prescription. Boise and Meridian ship fastest; rural ZIP codes may take an extra day.

One flat cash-pay price, the same in every Idaho ZIP code, no insurance needed. It covers your clinician, check-ins and messaging, and medication ships free once prescribed.

An Idaho-licensed clinician decides after reviewing your intake. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.

Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.

Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.

Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.

Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.

You answer health questions online in about 5 minutes. An Idaho-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.

Your first order arrives in 2–3 business days, and most patients start low and step up gradually. Your plan renews on a set schedule so refills arrive before you run out; change or cancel anytime in the portal.

Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.

Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.

Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.

Idaho Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.

Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.

A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.

Pallas serves all of Idaho with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No video visit is required.

More states

Rule changes affecting Idaho

  1. 2026-07-25 Correction — Idaho renamed its telehealth statute; Idaho Code §54-5701 and following is now the Idaho Virtual Care Access Act (formerly the Telehealth Access Act). Section numbers and substance are unchanged.Idaho Legislature, Title 54, Chapter 57; surfaced by our automated source check (PR #38).

From our state-by-state rules tracker. Get an email when a rule changes.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.